Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Adjustment of DOses of NIcotine in Smoking Cessation (ADONIS) [Phase 4]
Phase 4 clinical trial updating nicotine dosing for smoking cessation (ADONIS) has completed. The study examined dosing strategies for nicot…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits
This completed NCI clinical trial examines genetic factors and interrelationships among cancer risk-related behaviors and related complex tr…
-
CLINICAL_TRIALS trial_result · 2008-02-28Clinical Trial Update: Nicotine Replacement and Counseling In Adolescents [Phase 4]
Phase 4 trial update from University of California, San Francisco evaluating nicotine replacement therapy with counseling for adolescent smo…
-
CLINICAL_TRIALS trial_result · 2008-02-11Clinical Trial Update: Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study [Phase 1]
A randomized Phase 1 pilot trial evaluated whether yoga combined with cognitive behavioral therapy can prevent postpartum relapse to smoking…
-
CLINICAL_TRIALS trial_result · 2007-12-17Clinical Trial Update: Financial Incentives for Smoking Cessation [NA]
This update notes that a clinical trial at the University of Pennsylvania evaluating financial incentives for smoking cessation in individua…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: A Feasibility Study of Smoking Cessation Program in Radiation Oncology [NA]
A completed feasibility study evaluating a smoking cessation program in patients receiving radiation oncology care.
-
FDA approval · 2007-10-30FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Aveva Drug Delivery Systems, Inc.)
The FDA approved a supplemental application for the Nicotine Transdermal System by Aveva Drug Delivery Systems, Inc. (ANDA074612).
-
FDA approval · 2007-07-23FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
FDA approved a supplemental application for NICOTINE POLACRILEX MINT (nicotine polacrilex lozenge) submitted by Walgreens.
-
FDA approval · 2007-07-23FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor, a nicotine replacement therapy from Rugby Labora…
-
FDA approval · 2007-07-16FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
The FDA approved a supplemental application for Walgreens' NICOTINE POLACRILEX MINT, a nicotine polacrilex product intended to aid smoking c…
-
FDA approval · 2007-06-26FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) filed by Haleon US Holdings LLC.
-
FDA approval · 2007-06-26FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for NICORETTE 4MG FRUIT CHILL GUM (nicotine polacrylex) from Lil' Drug Store Products, expanding the…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking [Phase 1]
Phase 1 trial evaluated AFQ056 in combination with nicotine for reducing cigarette smoking; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of flexible dosing of CP-526,555 versus placebo for smoking cessation over 12 weeks.
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline [Phase 3]
A completed Phase 3 placebo-controlled trial evaluating the safety of varenicline for smoking cessation over 52 weeks.
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation [Phase 3]
A twelve-week Phase 3 trial evaluating the safety and efficacy of varenicline compared with placebo and Zyban (bupropion) for smoking cessat…
-
FDA approval · 2007-05-24FDA Approved: FOSTER AND THRIVE NICOTINE — Original Application (Strategic Sourcing Services LLC)
The FDA approved the original ANDA for Foster and Thrive Nicotine (nicotine polacrilex) from Strategic Sourcing Services LLC, a generic nico…
-
CLINICAL_TRIALS trial_result · 2007-05-17Clinical Trial Update: Theory-Based Interventions for Smoking and Obesity (Challenge) Trial [Phase 3]
A Phase 3 clinical trial (the Challenge trial) evaluating theory-based behavioral interventions for smoking and obesity has completed. The s…
-
FDA approval · 2007-04-13FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Sam's West Inc)
FDA approved a supplemental application for the Nicotine Transdermal System submitted by Sam's West Inc.
-
FDA approval · 2007-03-08FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
The FDA approved Walgreens' supplemental application for Nicotine Polacrilex Mint (nicotine polacrilex), expanding the approved nicotine rep…
-
FDA approval · 2007-03-08FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor, expanding its labeling for this nicotine replace…
-
FDA label_change · 2007-03-08FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum Original Flavor to expand labeling with the Original Flavor under …
-
CLINICAL_TRIALS trial_result · 2007-01-31Clinical Trial Update: Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers [NA]
A clinical trial update examining how nicotine affects neurocognitive performance in cigarette smokers; the study status is currently UNKNOW…
-
CLINICAL_TRIALS research · 2007-01-11Clinical Trial Update: CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change [Phase 1]
This clinical trial update describes the CHERL program, which aims to connect primary care patients with community resources to support beha…
-
FDA approval · 2006-12-15FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved an original ANDA for Bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC, providing a generic version of the an…